Related Experiment Video
Updated: Aug 11, 2026
08:49
Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart
Published on: May 11, 2018
Extracorporeal mechanical circulatory assist
Himanshu Patel1, Francis D Pagani
1University of Michigan Medical Center, 2120 Taubman Center, Box 0348, 1500 East Medical Center Drive, Ann Arbor, MI 48109-0348, USA.
Cardiology Clinics
|June 7, 2003
Summary
Temporary mechanical circulatory support (MCS) offers safe options for cardiogenic shock and heart failure. Future devices will expand choices, with optimal selection depending on individual patient needs and clinical situations.
Area of Science:
- Cardiology
- Biomedical Engineering
Background:
- Current mechanical circulatory support (MCS) provides safe and effective temporary solutions for patients with cardiogenic shock or refractory heart failure.
- Technological advancements are leading to the development of novel MCS devices.
Purpose of the Study:
- To review the current landscape of temporary mechanical circulatory support options.
- To anticipate the future of MCS device development and clinical application.
Main Methods:
- Literature review of existing and emerging temporary mechanical circulatory support technologies.
- Analysis of clinical scenarios and patient characteristics influencing device selection.
Main Results:
- Several safe and effective temporary MCS devices are currently available.
- Newer device designs are under development, promising expanded therapeutic options.
- Predicting the ultimate efficacy of future devices is challenging due to rapid innovation.
Conclusions:
- The choice of temporary MCS will likely involve a diverse range of devices.
- Optimal device selection will be tailored to specific clinical circumstances and patient profiles.
- Continued innovation in MCS technology is expected to enhance patient care for heart failure and cardiogenic shock.
